Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VAXXITEK HVT + IBD
- Development stage
- Unknown
- Lead developer
- Boehringer Ingelheim
- Modality
- Vaccines & Immunotherapeutics
- Administration
- In Ovo, Subcutaneous
01
Overview
VAXXITEK HVT + IBD is a **recombinant viral vector veterinary vaccine** for chickens developed by **Boehringer Ingelheim** to prevent **Marek's disease** and **infectious bursal disease**. The product uses **herpesvirus of turkey** as the live viral vector backbone and expresses the **VP2 protein** of **infectious bursal disease virus**, enabling dual protection: the HVT backbone provides protection against Marek's disease while recombinant VP2 expression induces protective immunity against IBD. It is administered at the hatchery either **in ovo** to 18-19 day embryonated eggs or to **day-old chicks**, and it has been described as the first marketed HVT-IBD vector vaccine and the platform product for the broader VAXXITEK poultry vaccine portfolio.
- Brand names
- VAXXITEK HVT + IBD
- Other names
- HVT-IBD vector vaccine
02
Targets
GaHV-2 (Gallid alphaherpesvirus 2)VP2 (Infectious bursal disease virus VP2 protein)
Beyond the preview
Go deeper on VAXXITEK HVT + IBD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VAXXITEK HVT + IBD.